Name: US Pre-Market SEC Filings Roundup — August 12, 2026
Creator: Gunpowder
Published: 2026-08-12T12:01:03.000Z
License: https://www.gunpowderalerts.com/terms

34 high priority 16 medium priority 50 total filings analysed

Executive Summary

Overnight filings reveal a market bifurcated between aggressive growth investment and insider profit-taking. Key themes include a surge in director-level stock awards at Nu Holdings and STEM, signaling long-term alignment, contrasted with substantial insider selling at LandBridge Co LLC ($93.8M) and Charles Schwab ($5.01M).

Earnings reports from Amcor and BETA Technologies show strong top-line growth driven by M&A and defense contracts, but with widening losses and cautious forward guidance, creating a mixed sentiment. Institutional filings from AI-Squared and Westpac highlight a continued focus on mega-cap tech and Chinese ADRs. The most actionable signals center on the transformative Berry acquisition at Amcor, the strategic investment in GCL Global's gaming subsidiary, and the complete exit of Goldman Sachs from Cantaloupe, which may indicate a loss of confidence in the stock.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Schedule 13G · Form 4 · Schedule 13D · 8-K · 13F

Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from August 11, 2026.

Investment Signals (11)

Amcor plc ↓
▲

Q4 net sales surged 26% YoY to $6.4B and adjusted EBITDA rose 32% to $1,045M, driven by the transformative Berry acquisition. Full-year GAAP net income more than doubled to $1,106M. However, organic volume growth was only ~0.5%, and FY2027 adjusted EPS guidance of $1.80-$1.90 implies a potential deceleration. [BULLISH/BEARISH]
BETA Technologies ↓
▲

Q2 revenue more than doubled YoY to $14.7M, and full-year revenue guidance was raised to $42M-$50M. However, the net loss widened to ($148.8M) from ($80.4M) and Adjusted EBITDA loss guidance was widened to ($400M)-($445M), signaling aggressive cash burn for certification. [BULLISH/BEARISH]
GCL Global Holdings ↓ (BULLISH)
▲

Its subsidiary 4Divinity received a $9.0M strategic investment from ADATA Technology, bringing total investment to $32.0M at a $350M valuation. Proceeds will be used to acquire high-profile game titles, creating a potential catalyst for the parent company's stock.
LandBridge Co LLC ↓ (BEARISH)
▲

Director Capobianco David N sold 1,250,000 Class A shares at $75.05 (~$93.8M), representing a massive insider liquidation. The selling group still owns ~61.4% of the company, but the scale of the sale is a significant bearish signal.
FEMASYS INC ↓ (BULLISH)
▲

Chief Clinical-Medical Affairs Mifek Jeffrey Gerald bought 3,125 shares at $3.20 (~$10K), a direct insider purchase. This open-market buy, combined with stock option awards to multiple directors, signals insider confidence at current levels.
SCHWAB CHARLES CORP ↓ (BEARISH)
▲

Co-Chairman Schwab Charles R. sold 46,445 shares at $107.78 (~$5.01M). While the sale is small relative to his massive holdings (30M+ shares), it is a notable insider disposal at a high stock price.
CANTALOUPE, INC. ↓ (BEARISH)
▲

Goldman Sachs completely exited its position, reporting a 0.0% stake as of June 30, 2026. This complete exit by a major institutional investor is a strong negative signal for the stock.
KOREA ELECTRIC POWER CORP ↓ (BEARISH)
▲

Q2 operating income fell 47.1% YoY to 1,129 billion KRW and net income dropped 76.4% to 278 billion KRW, despite flat revenues. This sharp profitability decline signals significant operational headwinds.
ANI PHARMACEUTICALS INC ↓ (BEARISH)
▲

SVP of Generics Gutwerg Ori sold 3,162 shares at $77.00 (~$243K). While a relatively small sale, insider selling at a generics company can signal concerns about pricing or pipeline.
Terreno Realty Corp ↓ (BEARISH)
▲

EVP Meyer John Tull sold 4,447 shares at $68.64 (~$305K). This is a routine sale by an executive but occurs in a sector facing headwinds from rising interest rates.
Nu Holdings Ltd. ↓ (BULLISH)
▲

Multiple directors were awarded Class A shares (totaling ~157,000 shares), including Director Sands Anita M (30,709 shares) and Director Reses Jacqueline D (27,096 shares). This pattern of stock awards is a strong signal of long-term alignment and retention.

Risk Flags (9)

LandBridge Co LLC / Massive Insider Sell-Off↓ [HIGH RISK]
▼

Director Capobianco David N and LandBridge Holdings LLC sold a combined 2.5M shares at $75.05 for ~$187.6M. This is a high-conviction sell signal from a controlling insider.
KOREA ELECTRIC POWER CORP / Profitability Collapse↓ [HIGH RISK]
▼

Q2 net income plunged 76.4% YoY and operating income fell 47.1%, despite flat revenues. The company is facing severe cost pressures or margin compression that could lead to dividend cuts or regulatory scrutiny.
BETA Technologies / Cash Burn Acceleration↓ [HIGH RISK]
▼

Adjusted EBITDA loss widened to ($109.8M) in Q2 from ($68.4M) a year ago. The company's full-year guidance for an EBITDA loss of ($400M)-($445M) implies a cash burn rate that will require significant future capital raises, diluting existing shareholders.
CANTALOUPE, INC. / Complete Institutional Exit↓ [HIGH RISK]
▼

Goldman Sachs, a sophisticated institutional investor, reported a 0.0% stake, indicating a complete exit from the position. This is a strong vote of no confidence.
i3 Verticals, Inc. / Complete Institutional Exit↓ [MEDIUM RISK]
▼

William Blair Investment Management reported a 0.0% stake, reflecting a complete exit from its previous position. This signals a loss of institutional confidence.
SCHWAB CHARLES CORP / Insider Selling at High↓ [MEDIUM RISK]
▼

Co-Chairman Charles Schwab sold $5.01M in stock. While routine for a founder, the timing near all-time highs could signal a perceived peak in valuation.
ANI PHARMACEUTICALS INC / Insider Sale by SVP↓ [LOW RISK]
▼

The SVP of Generics sold $243K in stock. This could indicate internal concerns about the generics pipeline or pricing environment.
Terreno Realty Corp / Insider Sale by EVP↓ [MEDIUM RISK]
▼

EVP Meyer sold $305K in stock. In a rising interest rate environment, insider sales in REITs are a red flag for potential dividend pressure or valuation concerns.
Amcor plc / Weak Organic Growth↓ [MEDIUM RISK]
▼

Despite a 57% surge in full-year net sales to $23.5B from the Berry acquisition, organic volume growth was only ~0.5% in Q4. The company's ability to generate organic growth post-M&A is questionable.

Opportunities (9)

Amcor plc / Post-Merger Synergy Play↓ (OPPORTUNITY)
◆

The transformative Berry acquisition drove a 57% revenue surge and a swing to GAAP profitability. With adjusted EBIT margins improving to 15.1% in Global Flexible Packaging, the company is well-positioned to deliver on cost synergies and deleverage from 3.5x-3.6x, creating a potential re-rating opportunity.
GCL Global Holdings / Strategic Investment Catalyst↓ (OPPORTUNITY)
◆

ADATA Technology's $9M investment at a $350M valuation for 4Divinity provides capital for high-profile game acquisitions. The partnership with the world's #2 DRAM manufacturer creates a unique hardware-software integration angle.
FEMASYS INC / Insider Buying Signal↓ (OPPORTUNITY)
◆

Chief Clinical-Medical Affairs Mifek Jeffrey Gerald bought $10K worth of stock at $3.20. This open-market purchase by a key executive, combined with stock option awards to multiple directors, suggests strong insider conviction at a low stock price.
Nu Holdings Ltd. / Director Alignment Through Stock Awards↓ (OPPORTUNITY)
◆

The award of ~157,000 Class A shares to multiple directors, including Anita Sands (30,709) and Jacqueline Reses (27,096), demonstrates strong board-level alignment with shareholders. This is a positive signal for long-term governance.
Eagle Point Income Co Inc. / Corporate Conversion Catalyst↓ (OPPORTUNITY)
◆

The company will convert to a Delaware Statutory Trust on August 24, 2026, with a 1:1 share conversion and uninterrupted NYSE listing. The estimated NAV of $12.30-$12.40 provides a potential floor for the common shares.
Twist Bioscience Corp / Institutional Accumulation↓ (OPPORTUNITY)
◆

William Blair Investment Management increased its stake to 3.5% (2,174,594 shares), up from a prior position. This passive accumulation by a reputable firm signals confidence in the company's long-term growth story.
Revolve Group, Inc. / New Institutional Stake↓ (OPPORTUNITY)
◆

William Blair disclosed a new 5.6% passive stake (2,333,717 shares). This is a significant new position in a fashion e-commerce company, signaling a potential turnaround or value play.
TIGO ENERGY, INC. / Insider Stock Awards↓ (OPPORTUNITY)
◆

CEO Alon Zvi was awarded 233,900 shares, and other executives received substantial awards (62,000-146,900 shares). While tax withholdings occurred, the large awards signal management's long-term commitment to the solar energy company.
AI-Squared Management Ltd / Chinese Tech Focus↓ (OPPORTUNITY)
◆

The fund's top holdings include PDD Holdings ($25.0M), Baidu ($17.9M), and JD.com ($13.0M), indicating a strong conviction in Chinese internet stocks. This could signal a sector bottom or value opportunity in Chinese ADRs.

Sector Themes (5)

Insider Profit-Taking in Growth & Energy
◆

LandBridge Co LLC ($187.6M) and Charles Schwab ($5.01M) saw significant insider selling, suggesting that insiders in high-growth and financial sectors are taking profits at current valuations. This contrasts with the stock award patterns at Nu Holdings and TIGO Energy, which signal long-term alignment. [Theme]
M&A-Driven Growth vs. Organic Stagnation
◆

Amcor's 57% revenue surge from the Berry acquisition contrasts with its 0.5% organic volume growth. Similarly, BETA Technologies' revenue doubling is driven by defense contracts, not scalable commercial sales. This theme highlights the risk of paying for growth that is not sustainable. [Theme]
Institutional Rotation Out of Small/Mid-Caps
◆

Goldman Sachs completely exited Cantaloupe and i3 Verticals, while William Blair exited i3 Verticals. This suggests a rotation away from smaller, unprofitable companies toward larger, more liquid names, as evidenced by Westpac's $1.62B portfolio heavily weighted toward mega-cap tech. [Theme]
Concentrated Institutional Interest in Chinese ADRs
◆

Both AI-Squared Management and Brilliance Asset Management have PDD Holdings as their top holding. This dual filing suggests a coordinated or thematic bet on Chinese internet stocks, potentially driven by valuation discounts and regulatory clarity. [Theme]
Cash Burn vs. Revenue Growth in Emerging Tech
◆

BETA Technologies and KEPCO both show a pattern of revenue growth failing to translate into profitability. BETA's EBITDA loss guidance of ($400M)-($445M) and KEPCO's 76% net income decline highlight the risks in capital-intensive industries. [Theme]

Watch List (8)

Amcor plc / Q1 FY2027 Earnings↓
👁

Watch for organic volume growth and synergy realization from the Berry acquisition. The company's ability to deleverage from 3.5x-3.6x will be a key metric. [Earnings expected late October 2026]
BETA Technologies / Certification Milestones↓
👁

The company's widened EBITDA loss guidance of ($400M)-($445M) implies significant cash burn. Watch for FAA certification updates or additional capital raises. [Ongoing]
LandBridge Co LLC / Further Insider Selling↓
👁

After the $187.6M insider sale, watch for any additional Form 4 filings. If the selling continues, it could signal a fundamental deterioration in the business. [Ongoing]
Eagle Point Income Co Inc. / Trust Conversion Date↓
👁

The conversion to a Delaware Statutory Trust on August 24, 2026, could lead to a re-rating. Watch for any NAV updates or changes in dividend policy post-conversion. [August 24, 2026]
KOREA ELECTRIC POWER CORP / Q3 2026 Earnings↓
👁

After a 76% net income decline in Q2, watch for any cost-cutting measures or regulatory changes that could impact profitability. [Earnings expected November 2026]
GCL Global Holdings / Game Acquisition Announcements↓
👁

With $32M in new capital, watch for announcements of high-profile game title acquisitions by its 4Divinity subsidiary. [Ongoing]
CANTALOUPE, INC. / Institutional Ownership Changes↓
👁

Following Goldman Sachs' complete exit, watch for other institutional filings to see if this is a broader trend or an isolated decision. [Next 13F deadline: November 14, 2026]
Revolve Group, Inc. / Q3 Earnings↓
👁

With a new 5.6% stake from William Blair, watch for any operational improvements or strategic shifts that could justify the institutional interest. [Earnings expected late October 2026]

Filing Analyses (50)

Karyopharm Therapeutics Inc. SC 13G/A neutral materiality 4/10

11-08-2026

Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 1,429,197.87 shares of Karyopharm Therapeutics Inc. common stock as of June 30, 2026, representing a 6.3% stake. The filing indicates a passive investment held in the ordinary course of business, with no intention to change or influence control of the issuer.

· The filing is an amendment (SC 13G/A) to a previous Schedule 13G.
· Goldman Sachs disclaims beneficial ownership of securities held in client accounts or certain investment entities where it acts as general partner or manager.
· The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934, indicating passive investment intent.
· The filing date is August 11, 2026, with the period covered as of June 30, 2026.
· The joint filing agreement and powers of attorney are included as exhibits.

FEMASYS INC 4 neutral materiality 5/10

11-08-2026

Director Larsen Charles was awarded 880 Stock Option (Right to Buy).

· Director Larsen Charles was awarded 880 Stock Option (Right to Buy)

ANI PHARMACEUTICALS INC 4 negative materiality 3/10

11-08-2026

SVP, GENERICS Gutwerg Ori sold 3,162 Common Stock at $77.00 (~$243K). Gutwerg Ori holds 75,534 shares after the transaction.

· SVP, GENERICS Gutwerg Ori sold 3,162 Common Stock at $77.00 (~$243K)

FEMASYS INC 4 positive materiality 6/10

11-08-2026

Chief Clinical-Medical Affairs Mifek Jeffrey Gerald bought 3,125 Common Stock at $3.20 (~$10K). Mifek Jeffrey Gerald holds 3,125 shares after the transaction.

· Chief Clinical-Medical Affairs Mifek Jeffrey Gerald bought 3,125 Common Stock at $3.20 (~$10K)

FEMASYS INC 4 neutral materiality 6/10

11-08-2026

Chief Clinical-Medical Affairs Mifek Jeffrey Gerald was awarded 6,250 Stock Option (Right to Buy).

· Chief Clinical-Medical Affairs Mifek Jeffrey Gerald was awarded 6,250 Stock Option (Right to Buy)

Nu Holdings Ltd. 4 neutral materiality 3/10

11-08-2026

Director Moreno Mejia Luis Alberto was awarded 25,290 Class A ordinary shares ("Class A Shares"). Moreno Mejia Luis Alberto holds 251,524 shares after the transaction.

· Director Moreno Mejia Luis Alberto was awarded 25,290 Class A ordinary shares ("Class A Shares")

Charlton Aria Acquisition Corp SC 13G/A neutral materiality 3/10

11-08-2026

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G/A disclosing beneficial ownership of 388,670 Class A ordinary shares of Charlton Aria Acquisition Corp, representing 4.5% of the outstanding shares as of June 30, 2026. The filing indicates the shares were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

· The filing is an amendment (Schedule 13G/A) filed on August 11, 2026, with a date as of change of August 11, 2026.
· Goldman Sachs Group is a Delaware corporation classified under SIC 6211 (Security Brokers, Dealers & Flotation Companies).
· Goldman Sachs & Co. LLC is a New York limited liability company and a registered broker-dealer and investment adviser.
· The filing includes a joint filing agreement and powers of attorney authorizing multiple attorneys-in-fact to execute filings on behalf of the companies.
· The securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

FEMASYS INC 4 neutral materiality 5/10

11-08-2026

Director Eichenbaum Kenneth D. was awarded 880 Stock Option (Right to Buy).

· Director Eichenbaum Kenneth D. was awarded 880 Stock Option (Right to Buy)

Nu Holdings Ltd. 4 neutral materiality 4/10

11-08-2026

Director LEONE DOUGLAS M was awarded 25,290 Class A ordinary shares ("Class A Shares"). LEONE DOUGLAS M holds 198,865 shares after the transaction.

· Director LEONE DOUGLAS M was awarded 25,290 Class A ordinary shares ("Class A Shares")

FEMASYS INC 4 neutral materiality 5/10

11-08-2026

Director Uzialko Edward R was awarded 880 Stock Option (Right to Buy).

· Director Uzialko Edward R was awarded 880 Stock Option (Right to Buy)

FEMASYS INC 4 neutral materiality 5/10

11-08-2026

Director Milnes Alistair was awarded 880 Stock Option (Right to Buy).

· Director Milnes Alistair was awarded 880 Stock Option (Right to Buy)

Twist Bioscience Corp SC 13G/A neutral materiality 5/10

11-08-2026

William Blair Investment Management, LLC filed an amended Schedule 13G disclosing its holding of 2,174,594 shares of Twist Bioscience Corp, representing a 3.5% beneficial ownership as of June 30, 2026. The filing shows a reduction from a prior position of 1,975,454 shares that the firm retains sole voting power over, though the overall number of shares reported increased versus the previous filing.

· The investment manager retains sole voting power over 1,975,454 shares.
· The filing is made under Rule 13d-1(b), indicating passive investment intent.
· The beneficial ownership decreased from the previous filing as a percentage of class (not quantified in the filing).

IAC Inc. SC 13G neutral materiality 3/10

11-08-2026

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC filed a Schedule 13G disclosing beneficial ownership of 5.2% of People Incorporated's common stock as of June 30, 2026. The filing indicates the shares were acquired and are held in the ordinary course of business, not for control purposes. No period-over-period comparisons are available as this is a snapshot disclosure.

· The filing is a Schedule 13G (passive investment disclosure), not a 13D (activist filing).
· Goldman Sachs & Co. LLC holds the entire reported position; Goldman Sachs Group is the parent holding company.
· The filing includes a joint filing agreement and powers of attorney dated July 2026.

i3 Verticals, Inc. SC 13G/A neutral materiality 2/10

11-08-2026

William Blair Investment Management, LLC filed an amended Schedule 13G with the SEC on August 11, 2026, reporting a 0.0% beneficial ownership stake in i3 Verticals, Inc. as of June 30, 2026. The filing indicates that William Blair holds no shares of i3 Verticals' common stock, reflecting a complete exit from its previous position.

· Filing is an amendment (13G/A) to a previous Schedule 13G.
· The filing is made under Rule 13d-1(b), indicating passive investment intent.
· William Blair Investment Management, LLC is based in Chicago, IL and is a Delaware entity.
· The report is as of June 30, 2026, and was filed on August 11, 2026.

Yorkville International Capital Corp. SC 13G neutral materiality 3/10

11-08-2026

Yorkville International Capital Sponsor, LLC and related entities filed a Schedule 13G disclosing beneficial ownership of 15,033,333 Class B ordinary shares (39.2% of total voting power) of Yorkville International Capital Corp. as of June 17, 2026. Mark Angelo individually holds an additional 150,000 founder shares, bringing the group's total to 15,183,333 shares (39.6%). The filing is a routine disclosure of insider ownership by the sponsor group and does not indicate any change in control or new acquisition.

· The Class B ordinary shares are convertible into Class A ordinary shares on a one-for-one basis, automatically upon or after a business combination, or at the holder's option before that.
· YA II PN, Ltd. holds an economic interest in a majority of the founder shares held by the Sponsor but reports 0 shares directly owned.
· The filing is made under Rule 13d-1(d), indicating the filers are passive investors not seeking control.
· The issuer is a blank check company (SIC 6770) headquartered in Mountainside, New Jersey.

CANTALOUPE, INC. SC 13G/A neutral materiality 3/10

11-08-2026

Goldman Sachs Group Inc. and its subsidiary Goldman Sachs & Co. LLC filed an amended Schedule 13G with the SEC on August 11, 2026, disclosing that they beneficially own 0 shares of Cantaloupe, Inc. common stock as of June 30, 2026. The filing indicates that Goldman Sachs has completely exited its position in Cantaloupe, holding a 0.0% stake, and the filing is made pursuant to Rule 13d-1(b) as the securities were acquired and held in the ordinary course of business.

· The filing is an amendment (Schedule 13G/A) filed on August 11, 2026, with a date of change of August 11, 2026.
· The securities are owned by Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser, which is a subsidiary of The Goldman Sachs Group, Inc.
· The filing includes a joint filing agreement and powers of attorney authorizing multiple individuals to execute filings on behalf of the entities.
· The filing disclaims beneficial ownership of securities held in client accounts or certain investment entities where Goldman Sachs acts as general partner or manager.

Nu Holdings Ltd. 4 neutral materiality 4/10

11-08-2026

Director Reses Jacqueline D was awarded 27,096 Class A ordinary shares ("Class A Shares"). Reses Jacqueline D holds 45,754 shares after the transaction.

· Director Reses Jacqueline D was awarded 27,096 Class A ordinary shares ("Class A Shares")

Nu Holdings Ltd. 4 neutral materiality 4/10

11-08-2026

Director PIACENTINI DIEGO was awarded 23,483 Class A ordinary shares ("Class A Shares"). PIACENTINI DIEGO holds 30,986 shares after the transaction.

· Director PIACENTINI DIEGO was awarded 23,483 Class A ordinary shares ("Class A Shares")

Nu Holdings Ltd. 4 neutral materiality 4/10

11-08-2026

Director Sands Anita M was awarded 30,709 Class A ordinary shares ("Class A Shares"). Sands Anita M holds 192,859 shares after the transaction.

· Director Sands Anita M was awarded 30,709 Class A ordinary shares ("Class A Shares")

Revolve Group, Inc. SC 13G neutral materiality 5/10

11-08-2026

William Blair Investment Management, LLC disclosed a 5.6% beneficial ownership stake in Revolve Group, Inc. as of June 30, 2026, holding 2,333,717 shares of common stock. The filing is a Schedule 13G, indicating passive investment intent, and the stake was acquired in the ordinary course of business without any control-related purpose.

· William Blair has sole voting power over 1,820,565 shares and sole dispositive power over all 2,333,717 shares.
· The filing is made under Rule 13d-1(b), confirming the filer is a passive institutional investor.
· The filing date is August 11, 2026, with the ownership snapshot as of June 30, 2026.

Nu Holdings Ltd. 4 neutral materiality 3/10

11-08-2026

Director Marcus David was awarded 25,290 Class A ordinary shares ("Class A Shares"). Marcus David holds 655,039 shares after the transaction.

· Director Marcus David was awarded 25,290 Class A ordinary shares ("Class A Shares")